Streetbeat News

Products Services

BIDU

IWF

NVDA

VGT

Nvidia continues to dominate the AI chip market despite challenges from Huawei, which struggles with its software platform. Nvidia's stock has surged 146% in the past year, though it recently traded down 7.65%. Investors can access Nvidia through ETFs like VGT and IWF.

Portfolio Pulse from Anusuya Lahiri

September 03, 2024 | 4:32 pm

AVGO

NVDA

Broadcom Inc. (NASDAQ:AVGO) shares are down as the company prepares to report its Q3 earnings. Analysts expect an EPS of $1.20 and revenue of $12.96 billion. The stock is also influenced by Nancy Pelosi's investment and the semiconductor sector's pressure, notably from Nvidia's sell-off. Technical analysis suggests a potential bullish reversal.

Portfolio Pulse from Vaishali Prayag

September 03, 2024 | 4:31 pm

GILD

Options trading for Gilead Sciences (NASDAQ:GILD) shows a bullish sentiment among large investors, with 55% of trades being bullish. The price target is between $80.0 and $87.5. Gilead's stock is currently up 1.28% at $80.01, but RSI suggests it may be overbought.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:30 pm

INTC

MSFT

TSM

TXN

VGT

XLK

Intel's position in the Dow Jones Industrial Average is under threat due to its underperformance in the AI sector and potential restructuring plans. Analysts suggest Nvidia or Texas Instruments could replace Intel in the Dow.

Portfolio Pulse from Anusuya Lahiri

September 03, 2024 | 4:26 pm

NFLX

Joey Chestnut broke his hot dog-eating record during a Netflix live special, highlighting Netflix's push into live sports and events. This strategy could boost Netflix's advertising revenue and subscriber base.

Portfolio Pulse from Chris Katje

September 03, 2024 | 4:25 pm

INTC

Intel has unveiled the Intel Core Ultra 200V processor family, focusing on improved efficiency and speed for laptops. The new processors offer up to 40% less power consumption, enhanced battery life, and significant performance gains, including AI capabilities.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 4:20 pm

RXRX

Recursion Pharmaceuticals' shares are declining following the announcement of top-line results from the SYCAMORE trial for REC-994 in symptomatic CCM patients.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 4:19 pm

PRAX

Praxis Precision Medicines Inc. (NASDAQ:PRAX) announced positive results from its Phase 2 EMBOLD study for the epilepsy drug relutrigine, showing significant reductions in motor seizures and improvements in patient behavior and communication. The drug was well tolerated with no serious adverse events leading to discontinuation.

Portfolio Pulse from Vandana Singh

September 03, 2024 | 4:18 pm

ASML

Recent options activity for ASML Holding (NASDAQ:ASML) shows a bearish sentiment among financial giants, with 55% of trades being bearish. The stock price is down 4.85% to $859.99, and the options market indicates a price window between $700 and $1120. ASML is a leader in photolithography systems for semiconductors, with major clients like TSMC, Samsung, and Intel.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:15 pm

GOVX

LUMN

NVDA

QQQ

SMCI

SPY

TSLA

In August 2024, Nvidia was the most-searched stock on Benzinga Pro, driven by strong earnings and guidance. Tesla, SPY, and QQQ were also among the top-searched tickers. Lumen Technologies and GeoVax Labs entered the top 10 due to financial results and health-related interest, respectively.

Portfolio Pulse from Chris Katje

September 03, 2024 | 4:12 pm